Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Amgen
Takeda
Perspective Therapeutics
Second Life Therapeutics
VM Oncology, LLC
Tanabe Pharma America, Inc.
Immunitas Therapeutics
NuCana plc
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
NGM Biopharmaceuticals, Inc
Gustave Roussy, Cancer Campus, Grand Paris
Shandong Cancer Hospital and Institute
Merus B.V.
Aminex Therapeutics, Inc.
NextCure, Inc.
NGM Biopharmaceuticals, Inc
Jacobio Pharmaceuticals Co., Ltd.
Cancer Research UK
Second Affiliated Hospital of Guangzhou Medical University
CytomX Therapeutics
Genmab
Kineta Inc.
ImmVira Pharma Co. Ltd
Incyte Corporation
Seagen Inc.
Incyte Corporation
NKGen Biotech, Inc.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)